0001572426-15-000125.txt : 20151109 0001572426-15-000125.hdr.sgml : 20151109 20151105140710 ACCESSION NUMBER: 0001572426-15-000125 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151105 FILED AS OF DATE: 20151105 DATE AS OF CHANGE: 20151105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nexvet Biopharma plc CENTRAL INDEX KEY: 0001618561 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: NATL INST FOR BIOPROCESSING RESEARCH STREET 2: FOSTERS AVENUE, MOUNT MERRION CITY: BLACKROCK CO. DUBLIN STATE: L2 ZIP: 00000 BUSINESS PHONE: 353 1 215 8100 MAIL ADDRESS: STREET 1: NATL INST FOR BIOPROCESSING RESEARCH STREET 2: FOSTERS AVENUE, MOUNT MERRION CITY: BLACKROCK CO. DUBLIN STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: NEXVET BIOPHARMA Ltd DATE OF NAME CHANGE: 20140903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Farrell Geraldine T CENTRAL INDEX KEY: 0001632385 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36828 FILM NUMBER: 151199935 MAIL ADDRESS: STREET 1: C/O NEXVET BIOPHARMA PLC STREET 2: NATL INST, FOSTERS AVENUE, MOUNT MERRION CITY: BLACKROCK STATE: L2 ZIP: 00000 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-11-05 0001618561 Nexvet Biopharma plc NVET 0001632385 Farrell Geraldine T C/O NEXVET BIOPHARMA PLC NIBRT; FOSTERS AVENUE, MOUNT MERRION BLACKROCK L2 IRELAND 0 1 0 0 VP Operations, General Counsel Ordinary Shares 2015-11-05 4 M 0 6195 .125 A 16953 I By Geraldine Therese Farrell & Andrew John Benston <Bulla Bulla Family A/C> Ordinary Shares 4300 D Ordinary Shares 132 I By Nexvet EBT Limited Options to purchase shares .125 2015-11-05 4 M 0 6195 0 D 2015-11-05 2023-11-05 Ordinary Shares 6195 6194 I By Geraldine Therese Farrell & Andrew John Benston <Bulla Bulla Family A/C> The reporting person and her spouse have shared voting and dispositive power with respect to these reported securities. The reporting person has sole voting and dispositive power over the reported securities pursuant to that certain Nominee Deed dated as of 11/14/14 by and between Nexvet EBT Limited and the persons named in the schedule thereto. Such Nominee Deed was executed in connection with the Issuer's November 2014 four-for-five share consolidation. 6,195 options vested and became exercisable on 11/5/15; a further 6,194 options will vest and be exercisable on 11/5/16. /s/ Geraldine T. Farrell 2015-11-05